Evidence map›Paper›PMID 26540282›Full record

ArticlePloS one2015

Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.

Patrizio Castagnola, Gabriele Zoppoli, Sergio Gandolfo, Massimiliano Monticone, Davide Malacarne, Gabriella Cirmena, David Brown, Cinzia Aiello, Massimo Maffei, Roberto Marino and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Leukoplakia and Immunology: New Chemoprevention Landscapes?International journal of molecular sciences · 2020
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Patrizio CastagnolaIRCCS AOU - San Martino -IST, Genoa, Italy.
Gabriele ZoppoliIRCCS AOU - San Martino -IST, Genoa, Italy.
Sergio GandolfoDepartment of Oncology, Oral Medicine and Oral Oncology Unit, University of Turin, Turin, Italy.
Massimiliano MonticoneIRCCS AOU - San Martino -IST, Genoa, Italy.
Davide MalacarneIRCCS AOU - San Martino -IST, Genoa, Italy.
Gabriella CirmenaDepartment of Internal Medicine, University of Genoa, Genoa, Italy.
David BrownJ.-C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Cinzia AielloIRCCS AOU - San Martino -IST, Genoa, Italy.
Massimo MaffeiDepartment of Internal Medicine, University of Genoa, Genoa, Italy.
Roberto MarinoDepartment of Oncology, Oral Medicine and Oral Oncology Unit, University of Turin, Turin, Italy.
Walter GiarettiIRCCS AOU - San Martino -IST, Genoa, Italy.
Monica PenteneroDepartment of Oncology, Oral Medicine and Oral Oncology Unit, University of Turin, Turin, Italy.
Ospedale Policlinico San Martino · ITUniversity of Turin · ITUniversity of Genoa · ITInstitut Jules Bordet · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral potentially malignant disorders (OPMDs) characterized by the presence of dysplasia and DNA copy number aberrations (CNAs), may reflect chromosomal instability (CIN) and predispose to oral squamous cell carcinoma (OSCC). Early detection of OPMDs with such characteristics may play a crucial role in OSCC prevention. The aim of this study was to explore the relationship between CNAs, histological diagnosis, oral subsite and aneuploidy in OPMDs/OSCCs. Samples from OPMDs and OSCCs were processed by high-resolution DNA flow cytometry (hr DNA-FCM) to determine the relative nuclear DNA content. Additionally, CNAs were obtained for a subset of these samples by genome-wide array comparative genomic hybridization (aCGH) using DNA extracted from either diploid or aneuploid nuclei suspension sorted by FCM. Our study shows that: i) aneuploidy, global genomic imbalance (measured as the total number of CNAs) and specific focal CNAs occur early in the development of oral cancer and become more frequent at later stages; ii) OPMDs limited to tongue (TNG) mucosa display a higher frequency of aneuploidy compared to OPMDs confined to buccal mucosa (BM) as measured by DNA-FCM; iii) TNG OPMDs/OSCCs show peculiar features of CIN compared to BM OPMDs/OSCCs given the preferential association with total broad and specific focal CNA gains. Follow-up studies are warranted to establish whether the presence of DNA aneuploidy and specific focal or broad CNAs may predict cancer development in non-dysplastic OPMDs.

Indexed as

AneuploidyCarcinoma, Squamous CellChromosomal InstabilityChromosome AberrationsDiploidyDNA Copy Number VariationsDNA, NeoplasmFemaleFlow CytometryFollow-Up StudiesGenomicsHumansMaleMouth MucosaMouth NeoplasmsPrecancerous ConditionsDNA, Neoplasm

Identifiers

PMID26540282
PMCPMC4634987
OpenAlexW2101256223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.